IntelGenx Announces Montreal's Douglas Mental Health University Institute as Ninth Montelukast VersaFilm(TM) Phase 2a Clinical Trial Site
Stock Information for IntelGenx Technologies Corp.
Loading
Please wait while we load your information from QuoteMedia.